Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

UNVERIFIED PROFILE

Are you Vincent Wai-Sun Wong?   Register this Author

Register author
Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Publications by authors named "Vincent Wai-Sun Wong"

Are you Vincent Wai-Sun Wong?   Register this Author

100Publications

1529Reads

50Profile Views

Reply to Sun et al.

Clin Infect Dis 2020 Jun;70(12):2748-2749

Department of Medicine and Therapeutics, Chinese University of Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz725DOI Listing
June 2020

Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice.

J Gastrointestin Liver Dis 2020 Jun 3;29(2):235-245. Epub 2020 Jun 3.

UCM Digestive Diseases, Virgen del Rocío University Hospital, University of Seville, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15403/jgld-775DOI Listing
June 2020

Modelling the Economic and Clinical Burden of Non-Alcoholic Steatohepatitis in East Asia: Data from Hong Kong.

Hepatol Res 2020 Jun 14. Epub 2020 Jun 14.

Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.13535DOI Listing
June 2020

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.

Lancet Gastroenterol Hepatol 2020 Jun 22. Epub 2020 Jun 22.

Department of Medicine and Therapeutics, and Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(20)30190-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308747PMC
June 2020

Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B.

J Hepatol 2020 May 16;72(5):847-854. Epub 2019 Dec 16.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.12.005DOI Listing
May 2020

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Gastroenterology 2020 May 4;158(6):1611-1625.e12. Epub 2020 Feb 4.

National Institute for Health Research Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, United Kingdom; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, United Kingdom; Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2020.01.043DOI Listing
May 2020

Epidemiology of nonalcoholic fatty liver disease in non-obese populations: meta-analytic assessment of prevalence, genetic, metabolic and histological profiles.

J Dig Dis 2020 May 5. Epub 2020 May 5.

Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1751-2980.12871DOI Listing
May 2020

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis.

Clin Gastroenterol Hepatol 2020 May 7. Epub 2020 May 7.

Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Nedlands, Australia; Department of Hepatology, Sir Charles Gairdner Hospital, Nedlands Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2020.04.083DOI Listing
May 2020

Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page".

J Hepatol 2020 May 15. Epub 2020 May 15.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2020.04.029DOI Listing
May 2020

SGLT2 Inhibitors in Liver Patients.

Clin Gastroenterol Hepatol 2020 May 16. Epub 2020 May 16.

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2020.05.021DOI Listing
May 2020

Confounding factors of non-invasive tests for nonalcoholic fatty liver disease.

J Gastroenterol 2020 May 25. Epub 2020 May 25.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, 9/F, Prince of Wales Hospital, 30-32 Ngan Shing Street, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-020-01686-8DOI Listing
May 2020

Application of transient elastography in nonalcoholic fatty liver disease.

Clin Mol Hepatol 2020 Apr 8;26(2):128-141. Epub 2019 Nov 8.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2019.0001nDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160347PMC
April 2020

Use of hepatitis B virus core-related antigen to evaluate natural history of chronic hepatitis B.

J Gastroenterol Hepatol 2020 Apr 15. Epub 2020 Apr 15.

Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.15058DOI Listing
April 2020

Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma.

Liver Cancer 2020 Apr 21;9(2):167-181. Epub 2019 Nov 21.

Department of Anatomical and Cellular Pathology, Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000504252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206612PMC
April 2020

Reply.

Hepatology 2020 Mar 5;71(3):1134. Epub 2020 Mar 5.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.31005DOI Listing
March 2020

Predicting NASH response with liver fat: Are we back to square one?

J Hepatol 2020 Mar 6;72(3):386-388. Epub 2019 Dec 6.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.10.024DOI Listing
March 2020

Application of point shear wave elastography in alcohol-related liver disease.

Hepatol Int 2020 Mar 6;14(2):161-163. Epub 2020 Mar 6.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12072-020-10027-zDOI Listing
March 2020

Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease.

J Gastroenterol Hepatol 2020 Feb 12;35(2):320-325. Epub 2019 Sep 12.

Department of Medicine, Singapore General Hospital, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14794DOI Listing
February 2020

How many deaths are caused by non-alcoholic fatty liver disease in the Asia-Pacific region?

Lancet Gastroenterol Hepatol 2020 Feb 15;5(2):103-105. Epub 2019 Dec 15.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30338-3DOI Listing
February 2020

Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B.

J Gastroenterol Hepatol 2020 Feb 7. Epub 2020 Feb 7.

Faculty of Medicine, Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.15007DOI Listing
February 2020

Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.

J Hepatol 2020 Jan 6;72(1):57-66. Epub 2019 Sep 6.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.08.023DOI Listing
January 2020

Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.

Gastroenterology 2020 01 28;158(1):215-225.e6. Epub 2019 Sep 28.

Institute of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong; Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.09.025DOI Listing
January 2020

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.

Aliment Pharmacol Ther 2019 11 16;50(9):1037-1048. Epub 2019 Sep 16.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15499DOI Listing
November 2019

Changing NAFLD Epidemiology in China.

Hepatology 2019 10;70(4):1095-1098

Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30848DOI Listing
October 2019

A new bile acid treatment for non-alcoholic fatty liver disease.

Lancet Gastroenterol Hepatol 2019 10 22;4(10):747-749. Epub 2019 Jul 22.

Department of Medicine and Therapeutics and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30183-9DOI Listing
October 2019

Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness.

Hepatology 2019 09 15;70(3):971-981. Epub 2019 Mar 15.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.30522
Publisher Site
http://dx.doi.org/10.1002/hep.30522DOI Listing
September 2019

Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease.

Clin Gastroenterol Hepatol 2019 Sep 28. Epub 2019 Sep 28.

Centre d'Investigation de la Fibrose Hépatique, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.09.027DOI Listing
September 2019

Non-alcoholic fatty liver disease in Asia: How is it different from the West?

J Gastroenterol Hepatol 2019 08;34(8):1267-1268

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14813DOI Listing
August 2019

Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis.

Transl Gastroenterol Hepatol 2019 19;4:53. Epub 2019 Jul 19.

Division of Gastroenterology and Hepatology, Avera Transplant Institute, University of South Dakota Sanford School of Medicine, Sioux Falls, SD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tgh.2019.06.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691078PMC
July 2019

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Hepatology 2019 06;69(6):2672-2682

Department of Pediatrics, School of Medicine and Nutrition Health Sciences, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30251DOI Listing
June 2019

Reply to: "NAFLD and beneficial effects of lifestyle intervention: Defining the meat of the matter".

J Hepatol 2019 06 2;70(6):1304. Epub 2019 Mar 2.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.02.008DOI Listing
June 2019

Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.

Aliment Pharmacol Ther 2019 06 25;49(12):1509-1517. Epub 2019 Apr 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15269DOI Listing
June 2019

Towards finite oral antiviral treatment for chronic hepatitis B.

Lancet Gastroenterol Hepatol 2019 04 20;4(4):260-262. Epub 2019 Feb 20.

Institute of Digestive Disease, Department of Medicine and Therapeutics, and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30045-7DOI Listing
April 2019

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.

J Hepatol 2019 03 25;70(3):361-370. Epub 2018 Oct 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.10.014DOI Listing
March 2019

Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285].

J Hepatol 2019 Mar 8;70(3):581. Epub 2019 Jan 8.

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan; Division of Gastroenterology, Taichung Veterans General Hospital, Taichung, Taiwan; Faculty of Medicine and Graduate Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Public Health, China Medical University, Taichung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.12.010DOI Listing
March 2019

Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.

Liver Int 2019 02 25;39(2):271-279. Epub 2018 Sep 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13953DOI Listing
February 2019

Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.

J Clin Exp Hepatol 2019 Jul-Aug;9(4):491-496. Epub 2019 Feb 7.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jceh.2019.01.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728533PMC
February 2019

Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.

J Gastroenterol Hepatol 2019 Jan 27;34(1):241-248. Epub 2018 Jun 27.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14311DOI Listing
January 2019

Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

J Hepatol 2018 12 22;69(6):1349-1356. Epub 2018 Aug 22.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.08.011DOI Listing
December 2018

Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations.

Ultrasound Med Biol 2018 12 9;44(12):2419-2440. Epub 2018 Sep 9.

Department of Radiology, Northeastern Ohio Medical University and Southwoods Imaging, Youngstown, Ohio, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ultrasmedbio.2018.07.008DOI Listing
December 2018

Letter: chronic kidney disease risk in patients with chronic hepatitis B-authors' reply.

Aliment Pharmacol Ther 2018 12;48(11-12):1324

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15031DOI Listing
December 2018

Current Prevention and Treatment Options for NAFLD.

Adv Exp Med Biol 2018;1061:149-157

Department of Medicine and Therapeutics and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-10-8684-7_12DOI Listing
November 2018

Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment.

Aliment Pharmacol Ther 2018 11 20;48(9):984-992. Epub 2018 Aug 20.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14945DOI Listing
November 2018

On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.

Am J Gastroenterol 2018 11 12;113(11):1629-1638. Epub 2018 Oct 12.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41395-018-0247-9DOI Listing
November 2018

Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?

J Gastroenterol Hepatol 2018 Oct 7;33(10):1787-1794. Epub 2018 May 7.

Institute of Digestive Disease, The Chinese University of Hong Kong, Sha Tin, Hong Kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgh.14150
Publisher Site
http://dx.doi.org/10.1111/jgh.14150DOI Listing
October 2018

Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.

J Hepatol 2018 Oct;69(4):793-802

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.05.009DOI Listing
October 2018

Is Modest Drinking Good for the Liver?

Clin Gastroenterol Hepatol 2018 09 27;16(9):1404-1406. Epub 2018 Mar 27.

Department of Medicine and Therapeutics, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.03.026DOI Listing
September 2018

Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.

Clin Infect Dis 2018 09;67(8):1278-1284

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy234DOI Listing
September 2018

Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

J Hepatol 2018 08 16;69(2):278-285. Epub 2018 Mar 16.

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan; Division of Gastroenterology, Taichung Veterans General Hospital, Taichung, Taiwan; Faculty of Medicine and Graduate Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Public Health, China Medical University, Taichung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.02.032DOI Listing
August 2018

Systematic review with meta-analysis: Change in liver stiffness during anti-viral therapy in patients with hepatitis B.

Dig Liver Dis 2018 08 15;50(8):787-794. Epub 2018 May 15.

Division of Gastroenterology, University of California San Diego, La Jolla, CA, United States; Division of Biomedical Informatics, University of California San Diego, La Jolla, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.05.005DOI Listing
August 2018

Noninvasive biomarkers in NAFLD and NASH - current progress and future promise.

Nat Rev Gastroenterol Hepatol 2018 08;15(8):461-478

University of Buenos Aires, Institute of Medical Research A Lanari, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41575-018-0014-9
Publisher Site
http://dx.doi.org/10.1038/s41575-018-0014-9DOI Listing
August 2018

Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen.

Clin Gastroenterol Hepatol 2018 05 12;16(5):765-773.e2. Epub 2017 Dec 12.

Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565173145
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2017.12.009DOI Listing
May 2018

Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory-wide cohort study.

J Gastroenterol Hepatol 2018 Apr 26;33(4):934-941. Epub 2018 Jan 26.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14003DOI Listing
April 2018

Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Am J Gastroenterol 2017 Dec 31;112(12):1812-1823. Epub 2017 Oct 31.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong,China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.389DOI Listing
December 2017

Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

J Hepatol 2017 11 24;67(5):902-908. Epub 2017 Jun 24.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.06.019DOI Listing
November 2017

New trends on obesity and NAFLD in Asia.

J Hepatol 2017 10 19;67(4):862-873. Epub 2017 Jun 19.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.06.003DOI Listing
October 2017

Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes.

J Hepatol 2017 Oct 6. Epub 2017 Oct 6.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.09.020DOI Listing
October 2017

Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients.

J Hepatol 2017 Oct 6. Epub 2017 Oct 6.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278173233
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2017.09.018DOI Listing
October 2017

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.

J Hepatol 2017 09 12;67(3):577-584. Epub 2017 May 12.

Centre d'Investigation de la Fibrose Hépatique, Hôpital Haut-Lévêque, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.05.005DOI Listing
September 2017

Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance".

J Hepatol 2017 Sep 19. Epub 2017 Sep 19.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.08.026DOI Listing
September 2017

Mechanism and prediction of HCC development in HBV infection.

Best Pract Res Clin Gastroenterol 2017 Jun 5;31(3):291-298. Epub 2017 May 5.

State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2017.04.011DOI Listing
June 2017